Submitted by Celso Magalhaes (celsomagalhaes@ufrrj.br) on 2017-06-21T11:22:42Z
No. of bitstreams: 1
2016 - Raquel Teixeira Ferreira.pdf: 4123117 bytes, checksum: d2271c63e8c851f1e25afd9a0bd8cf91 (MD5) / Made available in DSpace on 2017-06-21T11:22:42Z (GMT). No. of bitstreams: 1
2016 - Raquel Teixeira Ferreira.pdf: 4123117 bytes, checksum: d2271c63e8c851f1e25afd9a0bd8cf91 (MD5)
Previous issue date: 2016-03-30 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior - CAPES / Kalanchoe pinnata (KP) is popularly used for treating inflammatory diseases. This study
investigated the antinociceptive and anti-inflammatory potential of the KP flower aqueous
extract (KPFE), the ethyl acetate (EtOAcF), butanol (BuOHF) and aqueous (AqF) fractions
and the main flavonoid [quercetin 3-O-?-L-arabinopyranosyl (1??) ?-L-rhamnopyranoside]
(KPFV) of KP, as well as possible mechanisms of action. Swiss albino mice, male (25-35g)
were pretreated with KPFE (30-300 mg/kg, s.c.) producing dose-related inhibition of acetic
acid-induced writhing (ID50 164.8 mg/kg), and the subcutaneous administration of KPFE (300
mg/kg), EtOAcF (12 mg/kg), BuOHF (15 mg/kg) or AqF (210 mg/kg) reduced leukocyte
migration on carrageenan-induced pleurisy in mice at 56.1%, 47.3%, 39.6% and 43.1%,
respectively. At doses of up to 240 times smaller than KPFE, KPFV (0.3-3.0 mg/kg, s.c.), also
inhibited leukocyte migration (ID50 1.78 mg/kg). In croton oil-induced ear edema in mice,
KPFE (3-30 mg/kg, s.c.) and KPFV (0.3-3.0 mg/kg, s.c.) presented dose-related antiedematogenic
activity (KPFE - ID50 4.3 mg/kg, KPFV - ID50 0.76 mg/kg). Treatment with
KPFE reduced the MPO and TNF-? concentration in the pleural exudates on carrageenaninduced
pleurisy test, while KPFV inhibited both isoforms of cyclooxygenase (COX), with
IC50 3.8 x 10-5 M (22.1 ?g/mL) for COX-1 and a maximum COX-2 inhibition of 43.5% (IC50
>8.4 x10-5M or 50 ?g/mL). The selectivity index (COX-1 IC50/COX-2 IC50) was <0.44. These
results indicate that KPFE and KPFV produced anti-inflammatory and antinociceptive activity
through the COX inhibition and TNF-? reduction. This study reveals that the main flavonoid
in KP flowers and leaves plays an important role in the ethnomedicinal use of this species for
healing inflammatory processes / Kalanchoe pinnata (KP) ? popularmente utilizada para tratamento de doen?as inflamat?rias.
Este estudo investigou o potencial antinociceptivo e anti-inflamat?rio do extrato aquoso das
infloresc?ncias de KP (EAFL), a fra??o acetato de etila (FAcOEt), a fra??o butan?lica
(FBuOH), a fra??o aquosa (FAq) e o flavonoide majorit?rio [quercetina 3-O-?-Larabinopiranosil
(1??) ?-L-ramnopiranos?deo] (KPFV) de KP, assim como poss?veis
mecanismos de a??o. Camundongos albinos, machos (25-35g) foram pr?-tratados com EAFL
(30-300 mg/kg, s.c.), produzindo inibi??o dose dependente das contor??es induzidas por ?cido
ac?tico (DI50 164,8 mg/kg), e a administra??o subcut?nea de EAFL (300 mg/kg), FAcOEt (12
mg/kg) ou FBuOH (15 mg/kg) reduziu a migra??o leucocit?ria na pleurisia induzida por
carragenina em camundongos em 56,1%, 47,3%, 39,6% e 43,1%, respectivamente. Em doses
at? 240 vezes menores que o EAFL, KPFV (0,3-3,0 mg/kg, s.c.), tamb?m foi capaz de inibir a
migra??o leucocit?ria (DI50 1,78 mg/kg). No teste do edema de orelha induzido por ?leo de
cr?ton em camundongos, EAFL (3-30 mg/kg, s.c.) e KPFV (0,3-3,0 mg/kg, s.c.) apresentaram
atividade antiedematog?nica dose dependente (EAFL - DI50 4,3 mg/kg, KPFV - DI50 0,76
mg/kg). O tratamento com EAFL reduziu a concentra??o de MPO e de TNF-? no exsudato
pleural obtido do teste da pleurisia induzida por carragenina, enquanto o KPFV inibiu ambas
as isoformas de cicloxigenase (COX), com CI50 3,8 x 10-5M (22,1 ?g/mL) para COX-1 e um
m?ximo de inibi??o da COX-2 de 43,5% (CI50 >8,4 x10-5M ou 50 ?g/mL). O ?ndice de
seletividade (COX-1 CI50/COX-2 CI50) foi < 0,44. Estes resultados indicam que EAFL e
KPFV produziram atividade anti-inflamat?ria e antinociceptiva envolvendo a inibi??o da
COX e a redu??o de TNF-?. Este estudo revela que o principal flavonoide presente nas
infloresc?ncias e folhas de KP possui papel importante no uso etnomedicinal desta esp?cie
nos processos de natureza inflamat?ria
| Identifer | oai:union.ndltd.org:IBICT/oai:localhost:jspui/1802 |
| Date | 30 March 2016 |
| Creators | Ferreira, Raquel Teixeira |
| Contributors | Vanderlinde, Frederico Argollo, Silva, Alba Cen?lia Matos da, Malvar, David do Carmo, Pinto, Marcelo Alves, C?rtes, Wellington da Silva |
| Publisher | Universidade Federal Rural do Rio de Janeiro, Programa Multic?ntrico de P?s-Gradua??o em Ci?ncias Fisiol?gicas, UFRRJ, Brasil, Instituto de Ci?ncias Biol?gicas |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/doctoralThesis |
| Format | application/pdf |
| Source | reponame:Biblioteca Digital de Teses e Dissertações da UFRRJ, instname:Universidade Federal Rural do Rio de Janeiro, instacron:UFRRJ |
| Rights | info:eu-repo/semantics/openAccess |
| Relation | REFER?NCIAS BIBLIOGR?FICAS ABU-SOUD, H. M.; HAZEN, S. L. Nitric oxide modulates the catalytic activity of myeloperoxidase. The Journal of Biological Chemistry, v. 275, p. 5425-5430, 2000. AFONSO, P. V.; JANKA-JUNTTILA, M.; LEE, Y. J.; McCANN, C. P.; OLIVER, C. M.; AAMER, K. A.; LOSERT, W.; CICERONE, M. T.; PARENT, C. A. LTB4 is a signalrelay molecule during neutrophil chemotaxis. Developmental Cell, v. 22, p. 1079-1091, 2012. AFZAL, M.; GUPTA, G.; KAZMI, I.; RAHMAN, M.; AFZAL, O.; ALAM, J.; HAKEEM, K. R.; PRAVEZ, M.; GUPTA, R.; ANWAR, F. Anti-inflammatory and analgesic potential of a novel steroidal derivative from Bryophyllum pinnatum. Fitoterapia, v. 83, n. 5, p. 853-858, 2012a. AFZAL, M.; KAZMI, I.; KHAN, R.; SINGH, R.; CHAUHAN, M.; BISH, T.; ANWAR, F. Bryophyllum pinnatum: a review. International Journal of Research in Biological Sciences, v. 2, p. 143-149, 2012b. AGATI, G.; AZZARELLO, R.; POLLASTRI, S.; TATTINI, M. Flavonoids as antioxidants in plants: location and functional significance. Plant Science, v. 196, p. 67-76, 2012. AKINPELU, D. A. Antimicrobial activity of Bryophyllum pinnatum leaves. Fitoterapia, v. 71, p. 193-194, 2000. ALLORGE-BOITEAU, L. Madagascar centre de sp?ciation et d?origine Du genre Kalanchoe pinnata (Crassulaceae). In: LOUREN?O, W. R. Biog?ographie de Madagascar. Paris: Editions de L?ORSTOM, 1996. ALMEIDA, A.P. ; BAYER, B. M. ; HORAKOVA, Z. ; BEAVEN, M. A. Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: studies with carrageenan-induced inflammation in rats. The Journal of Pharmacology and Experimental Therapeutics, v. 214, n. 1, p. 74-79, 1980. ALMEIDA, A. P.; DA SILVA, A. G.; SOUZA, M. L. M.; LIMA, L. M. T. R.; ROSSIBERGMANN, B.; GON?ALVES DE MORAES, V. L.; COSTA, S. S. Isolation and chemical analysis of a fatty acid fraction of Kalanchoe pinnata with a potent lymphocyte suppressive activity. Planta Medica, v. 66, p. 134-137, 2000. ALMEIDA, M. Z. Plantas medicinais, 2 ed. Salvador: Editora EDUFBA, 2003. p. 31, 147, 181. ARANSIOLA, E. F., DARAMOLA, M. O.; IWALEWA, E. O.; SELUWA, A. M.; OLUFOWOBI, O. O. Anti-Diabetic Effect of Bryophyllum pinnatum Leaves. International Journal of Biological, Life Science and Engineering, v. 8, n. 1, 2014. ARCOLINE, T. Plantas Medicinais, sa?de e cura pelas plantas. Fitoterapia. S?o Paulo: On Line, 2003. n. 1, p. 34. 54 ARNHOLD, J. Free radicals ? Friends or foes? Properties, functions, and secretion of human myeloperoxidase. Biochemistry, v. 69, p. 4-9, 2004. BABIOR, B. M. The respiratory burst of phagocytes. Journal of Clinical Investigaton. v. 73, p. 599- 601, 1984. BAE, H.; JAYAPRAKASHA, G. K.; JIFON, J.; BHIMANAGOUDA, S. P. Extraction efficiency and validation of an HPLC method for flavonoid analysis in peppers. Food Chemistry, v. 130, p. 751-758, 2012. BAILEY, L. H. The standard Cyclopedia of Horticulture (1&2), The Macmillan Company, New York, 1953. BALUNAS, M. J.; KINGHORN, D. Drug discovery from medicinal plants. Life Sciences, v. 78, p. 431-441, 2005. BALZER, G. Bryophyllum. Ein Beitrag zu seina Pflanzen-morphologie. Berlin- Kleinmachnow, Gartenverlag. GmbH, 1949. BANKS, W. A.; KASTIN, A. J. Saturable transport of peptides across the blood-brain barrier. Life Science, v. 41, p. 1319-1338, 1987. BASBAUM, A. I.; BAUTISTA, D. M.; GR?GORY, S.; JULIUS, D. Cellular and molecular mechanisms of pain. Cell, v. 139, n. 2, p. 267-284, 2010. BASBAUM, A. I.; JESSELL, T. The Perception of Pain. In: KANDEL, E. R.; SCHWARTZ, J.; JESSELL, T. editors. Principles of Neuroscience. New York: Appleton and Lange; 2000. p. 472-491. BASBAUM, A. I.; JULIUS, D. Novos alvos contra a dor. Scientific American Brasil, v. 50, p. 76-83, 2006. BEERS, M. H.; BERKOW, R. Manual Merck. Ed. Roca Ltda, 2001. BERGSTR?M, S.; DUNER, H.; VON EULER, U. S.; PERNOW, B.; SJ?VALL, J. Observation on the effects on infusion of prostaglandin E in man. Acta Physiologica Scandinavian, v. 45, p. 145-151, 1959. BENINC?, J. P.; MONTANHER, A. B.; ZUCOLOTTO, S. M.; SCHENKEL, E. P.; FRODE, T. S. Evaluation of the anti-inflammatory efficacy of Passiflora edulis. Food Chemistry, v. 104, p. 1097-1105, 2007. BENYHE, S. Morphine: new aspects in the study of an ancient compound. Life Sciences, v. 55, p. 969-979, 1994. BESSON, J. M. The neurobiology of pain. Lancet, v. 353, n. 9164, p. 1610-1615, 1999. BESSON, J. M.; CHAOUCH, A. Peripheral and spinal mechanisms of nociception. Physiology Revision. v. 67, n. 1, p. 67-186, 1987. 55 BETSCHART, C.; VON MANDACH, U.; SEIFERT, B.; SCHEINERA, D.; PERUCCHINI, D.; FINK, D.; GEISSB?HLER, V. Randomized, double-blind placebocontrolled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine, v. 20, p. 351-358, 2013. BEVILACQUA, M. P.; POBER, J. S.; MAJEAU, G. R.; FIERS, W.; COTRAN, R. S. GIMBRONE, M. A. Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin. Proceedings of the National Academy of Sciences of the U.S.A., v. 83, n. 12, p. 4533-4537, 1986. BIESALSKI, H. K. Curr. Polyphenols and inflammation: basic interactions. Current Opinion in Clinical Nutrition and Metabolic Care, v. 10, p. 724-728, 2007. BISCHOFF, S. C. Quercetin: potentials in the prevention and therapy of disease. Current Opinion in Clinical Nutrition and Metabolic Care, v. 11, n. 6, p. 733-740, 2008. BISWAS, S. K.; CHOWDHURY, A.; DAS, J.; HOSEN, S. M. Z.; UDDIN, R.; RAHAMAN, S. Literature review on pharmacological potentials of Kalanchoe pinnata (Crassulaceae). African Journal of Pharmacy and Pharmacology, v. 5, n. 10, p. 1258-1262, 2011. BLACK, R. A.; RAUCH, C. T.; KOZLOSKY, C. J.; PESCHON, J. J.; SLACK, J. L.; WOLFSON, M. F.; CASTNER, B. J.; STOCKING, K. L.; REDDY, P.; SRINIVASAN, S.; NELSON, N.; BOIANI, N.; SCHOOLEY, K. A.; GERHART, M.; DAVIS, R.; FITZNER, J. N.; JOHNSON, R. S.; PAXTON, R. J.; MARCH, C. J.; CERRETTI, D. P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, v. 385, n. 6618, p. 729-733, 1997. BOITEAU, P. ; ALLORGE-BOUTEAU, L. Kalanchoe (Crassulac?es) de Madagascar. Syst?matique, ?cophysiologie et phytochimie. Karthala, Paris. 1995. BOND, M. Pain education issues in developing countries and responses to them by the international association for the study of pain. Pain Research & Management, v. 16, p. 404- 406, 2011. BOPDA, O. S. M.; LONGO, F.; BELLA, T. N.; EDZAH, P. M. O.; TA?WE, G. S.; BILANDA, D. C.; TOM, E. N. L.; KAMTCHOUING, P.; DIMO, T. Antihypertensive activities of the aqueous extract of Kalanchoe pinnata (Crassulaceae) in high salt-loaded rats. Journal of Ethnopharmacology, v.153, p. 400-407, 2014. BOTTING, R. M. Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927?2004). Journal of Thermal Biology, v. 31, p. 208-219, 2006. BRADLEY, J. R. TNF-mediated inflammatory disease. Journal of Pathology, v. 214, p. 149-160, 2008. BRAMWELL, D. How many plant species are there? Plant Talk. Wiltshire, v. 28, p. 32, 2000. 56 BRASIL. Minist?rio da sa?de. Ag?ncia Nacional de Vigil?ncia Sanit?ria. Resolu??o da Diretoria Colegiada (RDC) N? 10, de 9 de mar?o de 2010. Disp?e sobre a notifica??o de drogas vegetais junto ? Ag?ncia Nacional de Vigil?ncia Sanit?ria (ANVISA), 2010. BRESNIHAN, B.; ALVO-GARCIA, J. M.; COBBY, M.; DOHERTY, M.; DOMLJAN, Z.; EMERY, P.; NUKI, G.; PAVELKA, K.; RAU, R.; ROZMAN, B.; WALT, I.; WILLIAMS, B.; AITCHISON, R.; McCABE, D.; MUSIKIC, P. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis and Rheumatism, v. 41, p. 2196-2204, 1998. BRICKS, L. F.; SILVA, C. A. A. Toxicidade dos anti-inflamat?rios n?o-hormonais. Pediatria, v. 27, n. 3, p. 181-193, 2005. BROWNSTEIN, M. J. A brief history of opiates, opioid peptides, and opioid receptors. Proceedings of the National Academy of Sciences of the U.S.A., v. 90, p. 5391-5393, 1993. BUT, P. G.; MURAV?EV, R. A.; FOMINA, V. A.; ROGOVIN, V. V. Antimicrobial activity of myeloperoxidase from neutrophilic peroxisome. Biology Bulletin, v. 29, p. 266- 270, 2002. CALIXTO, J. B. Biodiversidade como fonte de medicamentos. Ci?ncia e Cultura, v. 55, p. 37, 2003. CALIXTO, J. B. Twenty-five years of research on medicinal plants in Latin America: A personal view. Journal of Ethnopharmacology, v. 100, p. 131-134, 2005. CALIXTO, J. B.; SIQUEIRA JR, J. M. Desenvolvimento de medicamentos no Brasil: Desafios. Gazeta M?dica da Bahia, v. 78, sup. 1, p. 98-106, 2008. CARMO, J. MESSIAS DO. Idade M?dia. In: Revista da flora medicinal. Ano XIV (6), junho, Rio de Janeiro, 1947. CARSWELL, E. A.; OLD, L. J.; KASSEL, R. L.; GREEN, S.; FIORE, N.; WILLIAMSON, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences of the U.S.A., v. 72, n. 9, p. 3666-3670, 1975. CARVALHO, M. M. M. J.; LODUCA, A.; PORTONI, A. G.; PIMENTA, C. A. M.; FIGUEIR?, J. A. B.; BORGES, L. M.; YENG, L. T.; TEIXEIRA, M. J.; K?VACS, M. J.; MURTA, S. G.; LORDELLO, S. R. M.; GUIMAR?ES, S. S. Dor - um estudo multidisciplinar. S?o Paulo. Summus Editorial, 1999. CARVALHO, W. A.; CARVALHO, R. D. S.; MEDRADO, V. C.; VIANNA, P. T. G. Biologia molecular dos receptores farmacol?gicos e seus sistemas efetores de interesse em anestesiologia. Revista Brasileira de Anestesiologia, v. 47, s. 2, p. 152-167, 1997. CAZAROLLI, L. H.; ZANATTA, L.; ALBERTON, E. H.; FIGUEIREDO, M. S. R. B. Mini-Reviews in Medicinal Chemistry, v. 8, p. 1429, 2008. 57 CEUSTERS, J.; GODTS, C.; PESHEV, D.; VERGAUWEN, R.; DYUBANKOVA, N.; LESCRINIER, E.; DE PROFT, M. P.; ENDE, W. V. D. Sedoheptulose accumulation under CO2 enrichment in leaves of Kalanchoe pinnata: a novel mechanism to enhance C and P homeostasis? Journal of Experimental Botany Advance, p. 1-11, 2013. CHANDRASEKHARAN, N. V.; DAI, H.; ROOS, K. L.; EVANSON, N. K.; TOMSIK, J.; ELTON, T. S.; SIMMONS, D. L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proceedings of the National Academy of Sciences of the U.S.A., v. 99, v. 21, p. 13926-13931, 2002. CHEN, Q. Methodology in pharmacological study on Chinese materia medica. Beijing: 7 People's Medical Publishing House, 1993. CHERNG, J.-M.; CHIANG, W.; CHIANG, L.-C. Immunomodulatory activities of common vegetables and spices of Umbelliferae and its related coumarins and flavonoids. Food Chemistry, v. 106, n. 3, p. 944-950, 2008. CHIBLI, L. A.; RODRIGUES, K. C. M.; GASPARETTO, C. M.; PINTO, N. C. C.; FABRI, R. L.; SCIO, E.; ALVES, M. S.; VIEIRA, G. D-V.; SOUSA, O. V. Antiinflammatory effects of Bryophyllum pinnatum (Lam.) Oken ethanol extract in acute and chronic cutaneous inflammation. Journal of Ethnopharmacology, v. 154, n. 2, p. 330-338, 2014. CHOI, S. J.; LEE, K. H.; PARK, H. S.; KIM, S. K.; KOH, C. M.; PARK, J. Y. Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes. Yonsei Medical Journal, v. 46, p. 818-826, 2005. CHUANG, H. H.; PRESCOTT, E. D.; KONG, H.; SHIELDS, S.; JORDT, S. E.; BASBAUM, A. I.; CHAO, M. V.; JULIUS, D. Bradykinin and nerve growth factor release the capsaicin receptor from ptdins(4,5) p2-mediated inhibition. Nature, v. 411, p. 957-962, 2001. CLARK, I. A. How TNF was recognized as a keymechanism of Disease. Cytokine and Growth Factor Reviews, v. 18, n. 3-4, p. 335-343, 2007. CLARK, T. P. The clinical pharmacology of cyclooxygenase-2-selective and dual inhibitors. Veterinary Clinics of North America: Small Animal Practice, v. 36, p. 1061-1085, 2006. COOK, N. C.; SAMMAN, S. Review: flavonoids-chemistry, metabolism, cardioprotective effects and dietary sources. Journal of Nutritional Biochemistry, v. 7, n. 2, p. 66-76, 1996. COPE, A. P.; ADERKA, D.; DOHERTY, M.; ENGELMANN, H.; GIBBONS, D.; JONES, A. C. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis and Rheumatism, v. 35, p. 1160- 1169, 1992. COSTA, S. S.; COUCEIRO, J. N. S. S.; SILVA, I. C. V.; MALVAR, D. C.; COUTINHO, M. A. S.; CAMARGO, L. M. M.; MUZITANO, M. F.; VANDERLINDE, F. A. 58 Flavonoids in the therapy and prophylaxis of flu: a patent review. Expert Opinion on Therapeutic Patents, v. 22, p.1111-1121, 2012. COSTA, R.; FERNANDES, E. S.; MENEZES-DE-LIMA, O. Jr; CAMPOS, M. M.; CALIXTO, J. B. Effect of novel selective non-peptide kinin B(1) receptor antagonists on mouse pleurisy induced by carrageenan. Peptides, v. 27, p. 2967-2975, 2006. COSTA, S. S.; MUZITANO, M. F.; CAMARGO, L. M. M.; COUTINHO, M. A. S. Therapeutic potential of Kalanchoe species: flavonoids and other secondary metabolites. Natural Product Communications, v. 3, p. 2151-2164, 2008. COSTA, S. S.; JOSSANG, A.; BODO, B. Propri?t?s biologiques et phytochimie des Kalanchoe. In: BOITEAU, P.; ALLORGE- BOITEAU, L. Kalanchoe (Crassulac?es) de Madagascar, Syst?matique, ?cophysiologie et phytochimie. Paris: Edition Karthala, p.219- 235, 1995. COUTINHO, M. A. S. Kalanchoe pinnata (Crassulaceae) e seus metab?litos: desenvolvimento de formula??o farmac?utica e investiga??o do seu potencial terap?utico em feridas cut?neas. 2013. Tese ? Universidade Federal do Rio de Janeiro, N?cleo de Pesquisa de Produtos Naturais. Rio de Janeiro. COUTINHO, M. A. S.; MUZITANO, M. F.; COSTA, S.S. Flavon?ides: Potenciais agentes terap?uticos para o processo inflamat?rio. Revista Virtual de Qu?mica, v.1, n. 3, p. 241-256, 2009. COUTINHO, M. A. S., MUZITANO, M. F., CRUZ, E. A., BERGONZI, M.C., KAISER, C.R., TINOCO, L.W., BILIA, A.R., VINCIERI, F.F., ROSSI-BERGMANN, B., COSTA, S.S. Flowers from Kalanchoe pinnata are a Rich Source of T Cell-Suppressive Flavonoids. Natural Product Communications, v. 6, n. 0, p. 1-5, 2012. CRUZ, E. A.; DA-SILVA, S. A. G.; MUZITANO, M. F.; SILVA, P. M. R.; COSTA, S. S.; ROSSI-BERGMANN, B. Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock. International Immunopharmacology, v. 8, p. 1616-1621, 2008. CRUZ, E. A.; REUTER, S.; MARTIN, H.; DEHZAD, N.; MUZITANO, M. F.; COSTA, S. S.; ROSSI-BERGMANN, B.; BUHL, R.; STASSEN, M.; TAUBE, C. Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease. Phytomedicine, v. 19, n. 2, p. 115-121, 2012. CUI, Y-Q.; JIA, Y-J.; ZHANG, T.; ZHANG, Q-B.; WANG, X-M. Fucoidan Protects against Lipopolysaccharide-Induced Rat Neuronal Damage and Inhibits the Production of Proinflammatory Mediators in Primary Microglia. CNS Neurosciences & Therapeutics, v. 18, p. 827-833, 2012. CUSHNIE, T. P. T.; LAMB, A. J. Antimicrobial activity of flavonoids. International Journal of Antimicrobial Agents, v. 26, p. 343-356, 2005. Di CARLO, G.; MASCOLO, N.; IZZO, A.; CAPASSO, F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Science, v. 65, p. 337-353, 1999. 59 DI STASI, L. C. Plantas Medicinais: arte e ci?ncia. S?o Paulo: Unesp, 1995, 230p. DINARELLO, C. A. Interleukin-1, interleukin-1 receptors and interleukin-1 antagonist. International Reviews of Immunology, v. 16, p. 457-499, 1998. DINARELLO, C. A.; BERNHEIM, H. A.; DUFF, G. W.; LEE, H. V.; NAGABHUSHAN, T. L.; HAMILTON, N. A.; COCEANI, F. Mechanisms of fever induced by recombinant human interferon. Journal of Clinical Investigation, n. 74, p. 906-913, 1984. DINARELLO, C. A.; GELFAND, J. A.; WOLFF, S. M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. Journal of the American Medical Association, Chicago, v. 269, n. 14, p. 1829-1835, 1993. DIXON, R. A.; DEY, P.; LAMB, C. J. Phytoalexins: enzymology and molecular biology. Advances in Enzymology and Related Areas of Molecular Biology, v. 55, p. 1-136, 1983. DJOUHRI, L.; AL OTAIBI, N.; KAHLAT, K.; SMITH, T.; SATHISH, J.; WENG, X. Persistent hindlimb inflammation induces changes in activation properties of hyperpolatization-activated current (Ih) in rat C-fiber nociceptores in vivo. Neuroscience, v. 301, p. 121-133, 2015. DRIESSEN, B. Pain: from sign to disease. Clinical Techniques in Equine Practice, v. 6, issue 2, p. 120-125, 2007. DUBNER, R.; BENNET, G. J. Spinal and trigeminal mechanisms of nociception. Annual Review of Neuroscience, v. 6, p. 381-418, 1983. DUBOIS, R. N.; ABRAMSON, S. B.; CROFFORD, L.; GUPTA, R. A.; SIMON, L. S.; Van De PUTTE, L. B.; LIPSKY, P. E. Cyclooxygenase in biology and disease. FASEB Journal, v. 12, n. 12, p. 1063-1073, 1998. ECOTERRAZAS.http://www.ecoterrazas.com/blog/kalanchoe-daigremontiana-el aranto -prodigioso. 14 de Agosto de 2013. EIGLER, A.; SINHA, B.; HARTMANN, G.; ENDRES, S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunology Today, Cambridge, v. 18, n. 10, p. 487- 492, 1997. EL ABDELLAOUI, S.; DESTANDAU, E.; TORIBIO, A.; ELFAKIR, C.; LAFOSSE, M.; RENIMEL, I.; ANDR?, P.; CANCELLIERI, P.; LANDEMARRE, L. Bioactive molecules in Kalanchoe pinnata leaves: extraction, purification, and identification. Analytical and Bioanalytical Chemistry, v. 398, p. 1329-1338, 2010. ENGLAND, S.; BEVAN, S. J.; DOCHERTY, R. J. Prostaglandin E2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. The Journal of Physiology, v. 495, p. 429-440, 1996. 60 ESPOSITO, E.; CUZZOCREA, S. TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Current Medicinal Chemistry, v. 16, p. 3152-3167, 2009. ESPOSITO, E.; CUZZOCREA, S. Anti-TNF therapy in the injured spinal cord. Trends in pharmacological sciences, v. 32, n. 2, p. 107-115, 2011. FABRICANT, D. S.; FARNSWORTH, N. R. Environmental Health Perspectives, v. 109, p. 69, 2001. FARQUHAR-SMITH, W. P. Anatomy, physiology and pharmacology of pain. Anaesthesia and Intensive Care Medicine, v. 9, n. 1, p. 3-7, 2007. FELDMAN, M.; BRENNAN, F. M.; MAINI, R. N. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology, v. 14, p. 397-440, 1996. FERNANDES, J. M. Kalanchoe brasiliensis CAMBESS e Kalanchoe pinnata (LAMARCK) PERSOON: Investiga??o qu?mica e avalia??o da atividade antiof?dica frente ao veneno de Bothrops jararaca. 2015. Disserta??o ? Universidade Federal do Rio Grande do Norte, Programa de P?s Gradua??o em Ci?ncias Farmac?uticas. Rio Grande do Norte. FERREIRA, S. H.; BARATA, L. E. S.; SALLES, S. L. M.; QUEIROZ, S. R. R.; NETO, N. E. H.; CORAZZA, R.; FARIAS, R. C. Medicamentos a partir de plantas medicinais no Brasil. Rio de Janeiro, Academia Brasileira de Ci?ncias, 1998. FILHO, M. M. M.; RAHAL, S. C. O uso de antiinflamat?rios inibidores COX II seletivos na osteoartrite canina. Veterin?ria e Zootecnia, v. 15, n. 3, p. 407-415, 2008. FISCHER, L. G.; SANTOS, D.; SERAFIN, C.; MALHEIROS, A.; DELLE MONACHE, F.; DELLE MONACHE, G.; CECHINEL FILHO, V.; DE SOUZA, M. M. Further antinociceptive properties of extracts and phenolic compounds from Plinia glomerata (Myrtaceae) leaves. Biological & Pharmaceutical Bulletin, v. 31, p. 235-239, 2008. FITZGERALD, G. A. COX-2 and beyond: Approaches to prostaglandin inhibition in human disease. Nature reviews. Drug discovery, v. 2, n. 11, p. 879-890, 2003. FITZGERALD, G. A.; PATRONO, C. The coxibs, selective inhibitor of cyclooxygenase-2. New England Journal of Medicine, v. 345, p. 433-442, 2001. FONSECA, A. G. Avalia??o da toxicidade do extrato das folhas de Kalanchoe brasiliensis (Crassulaceae) em camundongos swiss. 2014. Tese ? Universidade Federal do Rio Grande do Norte. Programa de P?s Gradua??o em Ci?ncias Farmac?uticas. Rio Grande do Norte. FORMAN, H. J.; TORRES, M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. American Journal of Respiratory and Critical Care Medicine, New York, v. 166, p. S4-S8, 2002. 61 FORMICA, J.V.; REGELSON, W. Review of the biology of quercetin and related bioflavonoids, Food and Chemical Toxicology, v. 33, p. 1061-1080, 1995. FRANCO, G. C. N.; MORETTI, D.; CAVALCANTE, P. F. C.; LOPES, L. C. Uma an?lise cr?tica sobre viabilidade do uso dos inibidores seletivos de COX II em odontologia. Revista de Odontologia da Universidade Cidade de S?o Paulo, v. 18, n. 1, p. 75-81, 2006. FR?DE, T. S.; SOUZA, G. E.; CALIXTO, J. B. The modulatory role played by TNFalpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine, v. 13, p. 162-168, 2001. FUNK, C. D.; FITZGERALD, G. A. COX-2 inhibitors and cardiovascular risk. Journal of Cardiovascular Pharmacology, v. 50, p. 470-479, 2007. GAIND, K. N.; GUPTA, R. L. Alkanes, Alkanols, Triterpens and Sterols of Kalanchoe pinnata. Phytochemistry, p. 11, 1972. GAIND, K. N.; GUPTA, R. L. Identification of Waxes from the Leaves of Kalanchoe pinnata. Planta Medica, v. 23, p. 193-197, 1974. GAUT, J. P.; YEH, G. C.; TRAN, H. D.; BYUN, J.; HENDERSON, J. P.; RICHTER, G. M.; BRENNAN, M. L.; LUSIS, A. J.; BELAAOUAJ, A.; HOTCHKISS, R. S.; HEINECKE, J. W. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proceedings of National Acadademy of Sciences of the U.S.A., v. 98, p. 11961-11966, 2001. GIBSON, P. R. Increased gut permeability in Crohn?s disease: is TNF-? the link? Gut, London, v. 53, n. 12, p. 1724-1725, 2004. GIERSE, J. K.; McDONALD, J. J.; HAUSER, S. D.; RANGWALA, S. H.; KOBOLDT, C. M.; SEIBERT, K. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. Journal of Biological Chemistry, v. 271, p. 15810-15814, 1996. GILMAN, A. G.; GOODMAN, L. S.; RALL, T. W.; MURAD, F. Goodman & Gilman's - The pharmacological basis of terapeutics. 12th ed. Rio de Janeiro: Grow-Hill, 2012. GILROY, D. W.; NEWSON, J.; SAWMYNADEN, P. WILLOUGHBY, D. A.; CROXTALL, J. D. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J, v.18, p. 489-498, 2004. GOLDBERG, D. S.; McGEE, S. J. Pain as a global public health priority, BMC PublicHealth, v. 11, p. 770, 2011. GORDALIZA, N. Natural products as leads to anticancer drugs. Clinical and Translational Oncology, v. 9, p. 767-776, 2007. GUARDIA, T.; ROTELLI, A. E.; JUAREZ, A. O.; PELZER, L. E. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il F?rmaco, v. 56, p. 683-687, 2001. 62 GUREJE, O.; VON KORFF, M.; SIMON, G. E.; GATER, R. Persistent pain and wellbeing: a world health organization study in primary care. Jama, v. 280, p. 147-151, 1998. GURIB-FAKIM, A. Medical plants: traditions of yesterday and drugs of tomorrow. Molecular aspects of medicine, v. 27, n. 1, p. 1-93, 2006. HALLIWELL, B.; GUTTERIDGE, J. M. C. Free radicals in biology and medicine. 3.ed. New York: Oxford University Press Inc., 1999. H?M?L?INEN, M.; NIEMINEN, R.; ASMAWI, M. Z.; VUORELA, P.; VAPAATALO, H.; MOILANEN, E. Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 expressions in activated macrophages. Planta medica, v. 7, n. 13, p. 1504-1511, 2011. HAMBURGER, M.; HOSTETTMANN, K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry, New York, v. 30, n. 12, p. 3864-3874, 1991. HANADA, T.; YOSHIMURA, A. Regulation of cytokine signaling and inflammation. Cytokine & Growth Factor Reviews, v. 13, p. 413-421, 2002. HANDA, S. S.; CHAWLA, A. S.; SHARMA, A. K. Plants with anti-inflammatory activity. Fitoterapia, LXIII, p. 3-31, 1992. HARBORNE, J. B.; WILLIAMS, C. A. Advances in flavonoid research since 1992. Phytochemistry, Oxford, v. 55, n. 6, p. 481-504, 2000. HARDY, J. D.; WOLFF, H. G.; GOODELL, H. Experimental evidence on the nature of cutaneous hyperalgesia. Journal of Clinical Investigation, v. 29, n. 1, p. 115-140, 1950. HARRIS, R. C.; BREYER, M. D. Physiological regulation of cyclooxygenase-2 in the kidney. American Journal of Physiology Renal Physiology, v. 281, F1-F11, 2001. HAVSTEEN, B. H. The biochemistry and medical significance of the flavonoids. Pharmacology Therapy, v. 96, p. 67-202, 2002. HAZEWINKEL, H. A. W.; VAN DEN BROM, W. E.; THEYSE, L. F. H.; POLLMEIER, M.; HANSON, P. D. Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urte crystal induced synovitis model of arthritis in dogs. Research in Veterinary Science, v. 84, p. 74-79, 2008. HEMA, D.; TIDJANI, M.; BASSENE, E.; POSSET, L.; GIONO-BARBER, H. Plantes m?dicinales africaines XXIV ?tude de l?ction anti-inflammatoire de Bryophyllum pinnatum (Crassulaceae). Plantes M?dicinales et Phytoth?rapie, v. 3, p. 231-235, 1986. HIL?RIO, M. O. E.; TERRERI, M. T.; LEN, C. A. Antiinflamat?rios n?o-hormonais: inibidores da ciclooxigenase 2. Journal of Pediatrics, v. 82, n. 5, 2006. HILL, R. S. Fossil evidence for the onset of xeromorphy and scleromorphy in Australian Proteaceae. Australian Systematic Botany, v. 11, p. 391-400, 1998. 63 HOLLMAN, P. C. H.; BATAN, M. B. Absorption, metabolism and health effects of dietary flavonoids in man. Biomedical Pharmacotherapy, v. 51, p. 305-310, 1997. HOSOMI, J. K.; GHELMAN, R.; QUINTINO, M. P.; DE SOUZA, E.; NAKAMURA, M. U.; MORON, A. F. Effects of chronic Bryophyllum pinnatum administration on Wistar rat pregnancy. Forsch Komplementmed, v. 21, n. 3, p. 184-189, 2014. HUTCHINGS, A.; SCOTT, A. H.; LEWIS, G.; CUNNINGHAN, A. Zulu Medicinal Plants, An Inventory. University of Natal Press, Pietermarizburg, South Africa. 1996. IASP - International Association for the Study of Pain. IASP Taxonomy, August 10th, 2011. Available from: http://www.iasp-pain.org. ICHIKAWA, M.; OGURA, M.; IIJIMA, T. Antiallergic flavones glycoside from Kalanchoe pinnatum. Patent 61, 118, 396 [86, 118, 319] (Cl. CO7H17/07), Apl 84/240, 282, 14 nov 1984; 4p- Chemical abstracts, 105, 178423q, 1986. JONES, R. Nonsteroidal Anti-inflamatory drug prescribing: past, present and future. American Journal of Medicine, v. 110, p. 4-7, 2001. JONES, T. C.; HUNT, R. D.; KING, N. W. Patologia Veterin?ria. S?o Paulo: Manole, 2000. JOSEPH, B.; SRIDHAR, S.; SANKARGANESH; JUSTINRAJ; EDWIN, B. T. Rare medicinal plant ? Kalanchoe pinnata. Research Journal of Microbiology, v. 6, n. 4, p. 322- 327, 2011. JULIUS, D; BASBAUM, A. I. Molecular mechanisms of nociception. Nature, v. 413, p. 203-210, 2001. KALISCH, P. A. An overview of research on the history of leprosy. International Journal of Leprosy, v. 43, n. 2, p. 129-144, 1975. KAMBOJ, A.; SALUJA, A. K. Bryophyllum pinnatum (Lam.) Kurz.: phytochemical and pharmacological profile: a review. Pharmacognosy Review, v. 3, p. 364-374, 2009. KANG, H.; ECKLUND, D.; LIU, M.; DATTA, S. K. Apigenin, a non-mutagenic dietary flavonoids, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells. Arithrits Research and Therapy, v. 11, p. 1-13, 2009. KAWAI, M.; HIRANO, T.; HIGA, S.; ARIMITSU, J.; MARUTA, M.; KUWAHARA, Y. Flavonoids and related compounds as anti-allergic substances. Allergology, v. 56, p. 113- 123, 2007. KELLY, E. H.; ANTHONY, R. T.; DENNIS, J. B. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. Journal of Nutritional Biochemistry, v. 13, n. 10, p. 572-584, 2002. KIDD, B. L.; URBAN, L. A. Mechanisms of inflammatory pain. British Journal of Anaesthesia, v. 87, n. 1, p. 3-11, 2001. 64 KIEFER, D. M. Today?s chemistry at work. 1997, December, 38. KIM, H. P.; SON, K. H.; CHANG, H. W.; KANG, S. S. J. Pharmacological Science, v. 96, p. 229, 2004. KING, J. N.; DAWSON, J.; ESSER, R. E.; FUJIMOTO, R.; KIMBLE, E. F.; MANIARA, W.; MARSHALL, P. J.; O?BYRNE, L.; QUADROS, E.; TOUTAIN, P. L.; LEE, P. Preclinical pharmacology of rofecoxib: a novel selective inhibitor of cyclooxygenase-2. Journal of Veterinary Pharmacology Therapeutics, v. 32, p. 1-17, 2009. KLEGGETVEIT, I. P.; NAMER, B.; SCHMIDT, R.; HELAS, T.; R?CKEL, M.; ORSTAVIK, K.; SCHMELZ, M.; JORUM, E. High spontaneous activity of C-nociceptors in painful polyneuropathy. Pain, v. 153, p. 2040-2047, 2012. KLINKHOFF, A. Biological agents for rheumatoid arthritis: targeting both physical function and structural damage. Drugs, v. 64, p. 1267-1283, 2004. KODAMA, M.; DAVIS, M.; FAUSTMAN, D. L. The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. CMLS, Cellular and Molecular Life Sciences, v. 62, p. 1-13, 2005. KODITHUWAKKU, N. D.; PAN, M.; ZHU, Y. L.; ZHANG, Y. Y.; FENG, Y. D.; FANG, W. R.; LI, Y. M. Antiinflammatory and antinociceptive effects of Chinese medicine SQ gout capsules and its modulation of pro-inflammatory cytokines focusing on gout arthritis. Journal of Ethnopharmacology, v. 150, n. 3, p. 1071-1079, 2013. KOEBERLE, A.; BAUER, J.; VERHOFF, M.; HOFFMANN, M.; NORTHOFF, H.; WERZ, O. Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E2 synthase-1. Biochemical and Biophysical Research Communications, v. 388, n. 2, p. 350-354, 2009. KOES, R.; VERWEIJ, W.; QUATTOCCHIO, F. Flavonoids: a colorful model for the regulation and evolution of biochemical pathways. Trends in Plant Sciences, v. 10, n. 5, p. 236-242, 2005. KONG, J. M.; GOH, N. K.; CHIA, L. S.; CHIA, T. F. Recent advances in traditional plant drugs and orchids. Acta Pharmacology Sinica, Beijing, v. 24, n. 1, p. 7-21, 2003. KRAYCHETE, D. C.; CALASANS, M. T.; VALENTE, C. M. L. Citocinas Pr?inflamat?rias e Dor. Revista Brasileira de Reumatologia, v. 46, n. 3, p. 199-206, 2006. KROGEL, C.; ANTONY V. B. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. The European Respiratory Journal, v. 10, p. 2411-2418, 1997. KUMAR, S.; GUPTA, A.; PANDEY, A. K. Calotropis procera root extract has capability to combat free radical mediated damage. ISRN Pharmacology, v. 2013, pp 8, 2013. KUMAR, V.; ABBAS, A. K.; FAUSTO, N.; ASTER, J. C. ROBBINS and COTRAN? Pathologic Basis of Disease, 8th edition, 2010, Elsevier. 65 KUMMER, C. L.; COELHO, T. C. R. B. Cycloxygenase-2 Inhibitors Nonsteroid Anti- Inflammatory Drugs: Current Issues. Revista Brasileira de Anestesiologia, v. 52, n. 4, p. 498- 512, 2002. KUO, P.C.; KUO, T. H.; SU, C. R.; LIOU, M. J.; WU, T. S. Cytotoxic principles and ?- pyrone ringopening derivatives of bufadienolides from Kalanchoe hybrida. Tetrahedron, v. 64, p. 3392-3396, 2008. KVATERNICK, V.; POLLMEIER, M.; FISCHER, J.; HANSON, P. D. Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses. Journal of Veterinary Pharmacology Therapeutics, v. 30, p. 208-217, 2007. KWON, J. H.; KIM, J. H.; CHOI, S. E.; PARK, K. H.; LEE, M. W. Inhibitory effects of phenolic compounds from needles of Pinus densiflora on nitric oxide and PGE2 production. Archives of Pharmacal Research, v. 33, n. 12, p. 2011-2016, 2010. LANDOLFI, R.; MOWER, R. L.; STEINER, M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochemistry and Pharmacology, v. 33, p. 1525-1530, 1984. LANZA, F. Clinical manifestation of myeloperoxidase deficiency. Journal of Molecular Medicine, v. 6, p. 676-681, 1998. LAWRENCE, T.; WILLOUGHBY, D. A.; GILROY, D. W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. National Review of Immunology, v. 2, n. 10, p. 787-795, 2002. LEE, H. N.; CHO, H. J.; LIM, D. Y.; KANG, Y.-H.; LEE, K. W.; PARK, J. H. Y. Mechanisms by which licochalcone e exhibits potent anti-inflammatory propert |
Page generated in 0.0048 seconds